Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Stud...

por Gadgeel, Shirish, Shaw, Alice T, Barlesi, Fabrice, Crino, Lucio, Yang, James CH, Dingemans, Anne-Marie, Kim, Dong-Wan, de Marinis, Filippo, Schulz, Mathias, Liu, Shiyao, Gupta, Ravindra, Smoljanovic, Vlatka, Ou, Sai-Hong Ignatius
Publicado 2019

Osimertinib in Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer and Leptomeningeal Metastases: The BLOOM Study

por Yang, James C.H., Kim, Sang-We, Kim, Dong-Wan, Lee, Jong-Seok, Cho, Byoung Chul, Ahn, Jin-Seok, Lee, Dae H., Kim, Tae Min, Goldman, Jonathan W., Natale, Ronald B., Brown, Andrew P., Collins, Barbara, Chmielecki, Juliann, Vishwanathan, Karthick, Mendoza-Naranjo, Ariadna, Ahn, Myung-Ju
Publicado 2020